Capital Fund Management (CFM)’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-19,039
Closed -$459K 1692
2017
Q2
$459K Sell
19,039
-108,759
-85% -$2.38M ﹤0.01% 1145
2017
Q1
$2.53M Buy
127,798
+36,282
+40% +$810K 0.02% 670
2016
Q4
$2.2M Sell
91,516
-18,476
-17% -$514K 0.02% 737
2016
Q3
$3.05M Buy
109,992
+44,481
+68% +$1.18M 0.03% 626
2016
Q2
$1.6M Sell
65,511
-75,567
-54% -$2.14M 0.02% 805
2016
Q1
$4.74M Buy
+141,078
New +$4.44M 0.05% 453
2015
Q3
Sell
-306,460
Closed -$15M 1611
2015
Q2
$14.8M Buy
+306,460
New +$12.9M 0.19% 146

Other funds holding PGEN

Capital Fund Management (CFM)'s PGEN Position: Q3 2017 in Review

Capital Fund Management (CFM) sold out of Precigen (PGEN) in Q3 2017, closing a stake of 19,039 shares — an estimated $459K sold.

Capital Fund Management (CFM) first reported a position in PGEN in Q2 2015 and held it in 7 quarters. The position peaked at $14.8M in Q2 2015. 155 funds tracked by Wall St. Rank hold PGEN as of Q3 2017.

  • Capital Fund Management (CFM) reported no remaining Precigen position as of Q3 2017 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 19,039 Precigen shares in Q3 2017, an estimated $459K.
  • Capital Fund Management (CFM) first reported a position in Precigen in Q2 2015 and held it in 7 quarters.
  • Capital Fund Management (CFM)'s Precigen position peaked at $14.8M in Q2 2015.
  • 155 funds tracked by Wall St. Rank held Precigen as of Q3 2017.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2017, filed 13 Nov 2017.